A new study shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.
Click here for original story, New path to treat advanced triple-negative breast cancer
Source: ScienceDaily
A new study shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.
Click here for original story, New path to treat advanced triple-negative breast cancer
Source: ScienceDaily